Claudio HoldCo A/S - CVR: 38205072

2023, DKK

11.06.2024

Bruttoresultat

Na.

Primær drift

-277'

Årets resultat

-267''

Aktiver

2.836''

Kortfristede aktiver

1.576''

Egenkapital

632''

Afkastningsgrad

-0 %

Soliditetsgrad

22 %

Likviditetsgrad

+500%

Resultat

11.06.2024

Årsrapport	2023 11.06.2024	2022 05.07.2023	2021 28.06.2022	2020 16.04.2021	2019 20.04.2020	2018 20.05.2019	2016 26.03.2018
Nettoomsætning			0	0	0	859.000.000	0
Resultat af primær drift	-277.000	-1.744.000	-437.000	-352.000	4.000	-108.000	-920.000
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0
Finansielle indtægter	48.239.000	42.000	2.522.000	1.386.000	0	0	0
Finansieringsomkostninger	-93.234.000	-4.989.000	-32.488.000	-38.236.000	-43.047.000	-48.357.000	-42.173.000
Andre finansielle omkostninger	0	0	0	0	0	0	0
Resultat før skat	-268.508.000	-193.300.000	-91.219.000	16.873.000	-62.047.000	-106.358.000	-39.968.000
Resultat	-266.947.000	-193.300.000	-93.205.000	17.151.000	-57.571.000	-101.165.000	-34.672.000
Forslag til udbytte	0	0	0	0	0	0	0

Aktiver

11.06.2024

Årsrapport	2023 11.06.2024	2022 05.07.2023	2021 28.06.2022	2020 16.04.2021	2019 20.04.2020	2018 20.05.2019	2016 26.03.2018
Kortfristede varebeholdninger	0	0	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	1.574.310.000	1.214.357.000	930.050.000	68.593.000	26.509.000	6.748.000	6.087.000
Likvider	1.357.000	30.571.000	432.000	56.000	0	606.000	0
Kortfristede aktiver	1.575.667.000	1.244.928.000	930.482.000	68.649.000	26.509.000	7.354.000	6.087.000
Immaterielle aktiver og goodwill	0	0	0	0	0	0	0
Finansielle anlægsaktiver	1.260.566.000	1.504.459.000	1.671.098.000	1.848.278.000	1.958.275.000	2.175.841.000	2.154.304.000
Materielle aktiver	0	0	0	0	0	0	0
Langfristede aktiver	1.260.566.000	1.504.459.000	1.671.098.000	1.848.278.000	1.958.275.000	2.175.841.000	2.154.304.000
Aktiver	2.836.233.000	2.749.387.000	2.601.580.000	1.916.927.000	1.984.784.000	2.183.195.000	2.160.391.000

Aktiver

11.06.2024

Passiver

11.06.2024

Årsrapport	2023 11.06.2024	2022 05.07.2023	2021 28.06.2022	2020 16.04.2021	2019 20.04.2020	2018 20.05.2019	2016 26.03.2018
Forslag til udbytte	0	0	0	0	0	0	0
Egenkapital	631.701.000	899.882.000	1.074.331.000	1.163.904.000	1.149.531.000	1.204.404.000	1.220.990.000
Hensatte forpligtelser	0	0	0	0	0	0	0
Langfristet gæld til banker	0	0	0	654.845.000	740.962.000	822.104.000	0
Anden langfristet gæld		0	0	215.000	0	0	0
Leverandører af varer og tjenesteydelser	0	0	0	0	0	0	0
Kortfristede forpligtelser	90.000	1.849.505.000	1.527.249.000	97.963.000	94.291.000	156.687.000	81.131.000
Gældsforpligtelser	2.204.532.000	1.849.505.000	1.527.249.000	753.023.000	835.253.000	978.791.000	939.372.000
Forpligtelser	2.204.532.000	1.849.505.000	1.527.249.000	753.023.000	835.253.000	978.791.000	939.372.000
Passiver	2.836.233.000	2.749.387.000	2.601.580.000	1.916.927.000	1.984.784.000	2.183.195.000	2.160.391.000

Passiver

11.06.2024

Nøgletal

11.06.2024

Årsrapport	2023 11.06.2024	2022 05.07.2023	2021 28.06.2022	2020 16.04.2021	2019 20.04.2020	2018 20.05.2019	2016 26.03.2018
Afkastningsgrad	0,0 %	-0,1 %	0,0 %	0,0 %	0,0 %	0,0 %	0,0 %
Dækningsgrad
Resultatgrad	Na.	Na.	Na.	Na.	Na.	-11,8 %	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-42,3 %	-21,5 %	-8,7 %	1,5 %	-5,0 %	-8,4 %	-2,8 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-0,3 %	-35,0 %	-1,3 %	-0,9 %	0,0 %	-0,2 %	-2,2 %
Soliditestgrad	22,3 %	32,7 %	41,3 %	60,7 %	57,9 %	55,2 %	56,5 %
Likviditetsgrad	1.750.741,1 %	67,3 %	60,9 %	70,1 %	28,1 %	4,7 %	7,5 %

Resultat

11.06.2024

Gæld

11.06.2024

Årsrapport

11.06.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 11.06.2024)

Information om virksomhedens regnskabsklasse:The annual report of Claudio HoldCo A/S for 2023 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to reporting class B entities and elective choice of certain provisions applying to reporting class C entities.

Beretning

11.06.2024

Dato for ledelsens godkendelse af årsrapporten:2024-05-27

Oplysning om usædvanlige forhold:As per 31 December 2023, the companies liquidity ratio is below 100, which could indicate uncertainties around the companies liquidity. The company’s structural financing is anchored in PMI’s overall financial strategy and structure and hence based on intercompany loans from the PMI-group. As a part of this strategy, DKK 1. 3 billion of the short-term intercompany debt has been converted to a long-term intercompany loan as per 1 March 2023. In addition the company has been granted a DKK 1. 9 billion short-term intercompany facility to support the continues development of the company, incl. support to the overall PMI strategy. It is Managements assessment that the provided funding is sufficient to support the companies strategic business plans for the coming year.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have discussed and approved the annual report of Claudio HoldCo A/S for the financial year 1 January - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Business Activities Claudio HoldCo A/S (Claudio HoldCo or” the Group”) was founded in 2016 with the purpose of investing in the fully owned subsidiaries Fertin Pharma A/S and NCP NextGen A/S. The Group is a specialist Contract Development and Manufacturing Organization (“CDMO”) offering innovative, high quality pharmaceutical and nutraceutical products for oral and intra oral delivery. The Group’s current main product formats (“delivery systems”) are chewing gum, lozenges, powders, fast dissolvable tablets, Zapliq® chewables, and Zapliq® chewing gum. The Group is the world’s largest independent developer and manufacturer of medicated chewing gum and has over recent years expanded into other specialized solid dosage oral and intra oral delivery systems. The Group strives to develop innovative oral and intra oral delivery systems that offer convenient and pleasurable delivery of active pharmaceutical ingredients (“APIs") and nutraceutical ingredients (“AIs") to patients and consumers. In 2023, the largest category continues to be high quality chewing gum and lozenges systems applied within Nicotine Replacement Therapy (“NRT”) category. Following the current diversification strategy, the Group is still utilizing its highly flexible delivery systems to grow business outside the NRT category, applying a wider range of APIs and AIs for OTC pharma and nutraceutical categories.